---
schema_version: "secwatch.filing_event.v1"
accession: "0000950170-23-053547"
form_type: "8-K"
ticker: null
cik: "0001445499"
company_name: "IMPEL PHARMACEUTICALS INC"
filed_at: "2023-10-16T23:59:59+00:00"
generated_at: "2026-06-09T23:11:41.451916+00:00"
event_type: "regulatory"
sentiment: "negative"
materiality_score: 0.85
calibrated_materiality_score: 0.85
confidence: "high"
source: SEC EDGAR
---

# Impel Pharmaceuticals receives Nasdaq delisting notice for failure to meet MVLS/MVPHS minimums

## Summary
- Nasdaq notified Impel on Oct 10, 2023, that it failed to regain compliance with $50M MVLS and $15M MVPHS requirements.
- Trading suspension of common stock (IMPL) set for Oct 19, 2023, unless company requests hearing.
- Impel intends to appeal the delisting determination and request a hearing before a Nasdaq Hearings Panel.
- Appeal would automatically stay suspension pending the Panel's decision.

## SEC filing metadata
- accession: 0000950170-23-053547
- form_type: 8-K
- cik: 0001445499
- company_name: IMPEL PHARMACEUTICALS INC
- filed_at: 2023-10-16T23:59:59+00:00
- event_type: regulatory
- sentiment: negative
- materiality_score: 0.85
- calibrated_materiality_score: 0.85
- confidence: high
- sec_items: 3.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1445499/000095017023053547/0000950170-23-053547-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1445499/000095017023053547/impl-20231010.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0000950170-23-053547
- JSON: https://secwatch.observer/filing/0000950170-23-053547.json
- Plain text: https://secwatch.observer/filing/0000950170-23-053547.txt

## Key facts
- Listing & Compliance Notices
  IMPEL PHARMACEUTICALS INC received a nasdaq deficiency notice notice regarding market value (rules 5450(b)(2)(A), 5450(b)(2)(C)).
  - Exchange: nasdaq
  - Notice: deficiency notice
  - Deficiency: market value
  - Rules: 5450(b)(2)(A), 5450(b)(2)(C)
  source text: April 11, 2023, from the Listing Qualifications Department (the “Staff”) of The Nasdaq Stock Market LLC (“Nasdaq”) notifying the Company that for the preceding 30 consecutive business days, the Company’s Market Value of Listed Securities (“MVLS”) was below the minimum of $50 million required for continued listing on Nasdaq pursuant to Nasdaq Listing Rule 5450(b)(2)(A) (the “MVLS Requirement”) and the Company’s Market Value of Publicly-held Securities (“MVPHS”) was below the minimum $15 million required for continued listing on Nasdaq pursuant to Nasdaq Listing Rule 5450(b)(2)(C) (the “MVPHS Re
  evidence_url: https://www.sec.gov/Archives/edgar/data/1445499/000095017023053547/0000950170-23-053547-index.htm

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.